WHO ICTRP trial
A clinical trial to study and compare the effects of two drugs amitriptyline and…
CTRI/2010/091/001036 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/001036 |
|---|---|
| Public title | A clinical trial to study and compare the effects of two drugs amitriptyline and duloxetine in patients with type 2 diabetes mellitus with neuropathic pain |
| Scientific title | A randomized double blind Trial comparing Efficacy and Safety of Duloxetine vs. Amitriptyline in painful Diabetic Neuropathy |
| Primary sponsor | PGIMER |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: null- PAINFUL DIABETIC NEUROPATHY |
| Interventions | Intervention1: DULOXETINE: To start with, 20mg/ day for two weeks was given. In case off inadequate response, the dose was increased to 40mg/day for another 2 weeks. If pain is still not controlled, the next higher dose 60 mg/day was given… |
| Registration date | Jul 22, 2010 |
| Target size | 60 |
| Secondary IDs | 7778/PG-2Trg/2008/35-50-51 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: